ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

In Brief: Nominations Open For Bristol-Myers Award; New Surgical Oncology Chair At South Florida

September 7, 1984

Healthy Weight, Lower Stress May Result In Fewer Changes Associated With Aging

March 27, 2009

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997

Bladder Cancer Epidemiological Study Involves 3,000 Patients

March 2, 1979